nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Prednisone—Crohn's disease	0.635	1	CpDpCtD
Sumatriptan—SLCO1B1—Sulfasalazine—Crohn's disease	0.08	0.348	CbGbCtD
Sumatriptan—SLCO1A2—Prednisone—Crohn's disease	0.0678	0.295	CbGbCtD
Sumatriptan—ABCG2—Sulfasalazine—Crohn's disease	0.0636	0.277	CbGbCtD
Sumatriptan—ABCB1—Prednisone—Crohn's disease	0.0183	0.0798	CbGbCtD
Sumatriptan—HTR3A—enteric nervous system—Crohn's disease	0.0144	0.467	CbGeAlD
Sumatriptan—HTR3A—myenteric nerve plexus—Crohn's disease	0.0109	0.354	CbGeAlD
Sumatriptan—HTR3A—digestive system—Crohn's disease	0.000827	0.0268	CbGeAlD
Sumatriptan—SLCO1B1—digestive system—Crohn's disease	0.000802	0.026	CbGeAlD
Sumatriptan—SLCO1A2—digestive system—Crohn's disease	0.000653	0.0212	CbGeAlD
Sumatriptan—MAOA—mammalian vulva—Crohn's disease	0.000583	0.0189	CbGeAlD
Sumatriptan—Tenderness—Mesalazine—Crohn's disease	0.000525	0.00654	CcSEcCtD
Sumatriptan—Vasodilation procedure—Mesalazine—Crohn's disease	0.000521	0.00649	CcSEcCtD
Sumatriptan—Vasodilation—Mesalazine—Crohn's disease	0.000521	0.00649	CcSEcCtD
Sumatriptan—Pancreatitis—Mercaptopurine—Crohn's disease	0.000519	0.00646	CcSEcCtD
Sumatriptan—Vasculitis—Azathioprine—Crohn's disease	0.000515	0.00641	CcSEcCtD
Sumatriptan—MAOA—digestive system—Crohn's disease	0.000512	0.0166	CbGeAlD
Sumatriptan—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00051	0.00636	CcSEcCtD
Sumatriptan—Rectal haemorrhage—Mesalazine—Crohn's disease	0.000507	0.00631	CcSEcCtD
Sumatriptan—ABCG2—mammalian vulva—Crohn's disease	0.000506	0.0164	CbGeAlD
Sumatriptan—Oropharyngeal pain—Mesalazine—Crohn's disease	0.000504	0.00627	CcSEcCtD
Sumatriptan—Dysmenorrhoea—Mesalazine—Crohn's disease	0.000504	0.00627	CcSEcCtD
Sumatriptan—Pancytopenia—Mercaptopurine—Crohn's disease	0.000503	0.00626	CcSEcCtD
Sumatriptan—Colitis—Azathioprine—Crohn's disease	0.000483	0.00601	CcSEcCtD
Sumatriptan—Neck pain—Mesalazine—Crohn's disease	0.000463	0.00577	CcSEcCtD
Sumatriptan—Musculoskeletal pain—Mesalazine—Crohn's disease	0.000463	0.00577	CcSEcCtD
Sumatriptan—Eructation—Mesalazine—Crohn's disease	0.00045	0.0056	CcSEcCtD
Sumatriptan—Melaena—Mesalazine—Crohn's disease	0.000447	0.00557	CcSEcCtD
Sumatriptan—Cystitis noninfective—Mesalazine—Crohn's disease	0.000447	0.00557	CcSEcCtD
Sumatriptan—Cystitis—Mesalazine—Crohn's disease	0.000442	0.00551	CcSEcCtD
Sumatriptan—Colitis—Mesalazine—Crohn's disease	0.00044	0.00547	CcSEcCtD
Sumatriptan—Skin exfoliation—Mesalazine—Crohn's disease	0.000437	0.00544	CcSEcCtD
Sumatriptan—Bladder pain—Mesalazine—Crohn's disease	0.000414	0.00516	CcSEcCtD
Sumatriptan—Lymphadenopathy—Mesalazine—Crohn's disease	0.00039	0.00485	CcSEcCtD
Sumatriptan—Ear pain—Mesalazine—Crohn's disease	0.00039	0.00485	CcSEcCtD
Sumatriptan—Immune system disorder—Mercaptopurine—Crohn's disease	0.000383	0.00477	CcSEcCtD
Sumatriptan—Photosensitivity—Mesalazine—Crohn's disease	0.000379	0.00471	CcSEcCtD
Sumatriptan—Hypothyroidism—Prednisone—Crohn's disease	0.000377	0.0047	CcSEcCtD
Sumatriptan—Gastroenteritis—Mesalazine—Crohn's disease	0.000375	0.00467	CcSEcCtD
Sumatriptan—Deafness—Mesalazine—Crohn's disease	0.000372	0.00463	CcSEcCtD
Sumatriptan—Eczema—Mesalazine—Crohn's disease	0.00037	0.00461	CcSEcCtD
Sumatriptan—Eye pain—Mesalazine—Crohn's disease	0.000368	0.00458	CcSEcCtD
Sumatriptan—Melatonin—MPO—Crohn's disease	0.000363	1	CrCbGaD
Sumatriptan—Peptic ulcer—Prednisone—Crohn's disease	0.000362	0.00451	CcSEcCtD
Sumatriptan—Renal failure acute—Mesalazine—Crohn's disease	0.00036	0.00448	CcSEcCtD
Sumatriptan—Atrial fibrillation—Mesalazine—Crohn's disease	0.000351	0.00437	CcSEcCtD
Sumatriptan—Thirst—Mesalazine—Crohn's disease	0.000349	0.00435	CcSEcCtD
Sumatriptan—Dermatitis bullous—Mesalazine—Crohn's disease	0.000348	0.00433	CcSEcCtD
Sumatriptan—Myopathy—Prednisone—Crohn's disease	0.000345	0.0043	CcSEcCtD
Sumatriptan—Arthritis—Mesalazine—Crohn's disease	0.000342	0.00426	CcSEcCtD
Sumatriptan—Anaemia—Mercaptopurine—Crohn's disease	0.000341	0.00424	CcSEcCtD
Sumatriptan—Osteoarthritis—Mesalazine—Crohn's disease	0.000332	0.00414	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000332	0.00414	CcSEcCtD
Sumatriptan—Dermatitis atopic—Prednisone—Crohn's disease	0.000327	0.00408	CcSEcCtD
Sumatriptan—Migraine—Mesalazine—Crohn's disease	0.000327	0.00407	CcSEcCtD
Sumatriptan—Arthralgia—Mercaptopurine—Crohn's disease	0.000314	0.00391	CcSEcCtD
Sumatriptan—Pancreatitis—Azathioprine—Crohn's disease	0.000309	0.00385	CcSEcCtD
Sumatriptan—Memory impairment—Prednisone—Crohn's disease	0.000309	0.00384	CcSEcCtD
Sumatriptan—Liver function test abnormal—Mesalazine—Crohn's disease	0.000307	0.00382	CcSEcCtD
Sumatriptan—Abdominal discomfort—Azathioprine—Crohn's disease	0.000302	0.00376	CcSEcCtD
Sumatriptan—Oedema—Mercaptopurine—Crohn's disease	0.000301	0.00375	CcSEcCtD
Sumatriptan—Pancytopenia—Azathioprine—Crohn's disease	0.0003	0.00373	CcSEcCtD
Sumatriptan—Cramp muscle—Mesalazine—Crohn's disease	0.000299	0.00373	CcSEcCtD
Sumatriptan—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000295	0.00367	CcSEcCtD
Sumatriptan—Gastritis—Mesalazine—Crohn's disease	0.000294	0.00366	CcSEcCtD
Sumatriptan—Skin disorder—Mercaptopurine—Crohn's disease	0.000292	0.00364	CcSEcCtD
Sumatriptan—MAOA—lymph node—Crohn's disease	0.000292	0.00947	CbGeAlD
Sumatriptan—Abdominal distension—Mesalazine—Crohn's disease	0.000289	0.0036	CcSEcCtD
Sumatriptan—ABCB1—epithelium—Crohn's disease	0.000287	0.00931	CbGeAlD
Sumatriptan—Dysphagia—Mesalazine—Crohn's disease	0.000287	0.00358	CcSEcCtD
Sumatriptan—Influenza—Mesalazine—Crohn's disease	0.000287	0.00358	CcSEcCtD
Sumatriptan—Asthma—Mesalazine—Crohn's disease	0.000287	0.00358	CcSEcCtD
Sumatriptan—Bronchospasm—Mesalazine—Crohn's disease	0.000283	0.00352	CcSEcCtD
Sumatriptan—Pancreatitis—Mesalazine—Crohn's disease	0.000282	0.00351	CcSEcCtD
Sumatriptan—Angina pectoris—Mesalazine—Crohn's disease	0.00028	0.00348	CcSEcCtD
Sumatriptan—Contusion—Prednisone—Crohn's disease	0.000278	0.00346	CcSEcCtD
Sumatriptan—Bronchitis—Mesalazine—Crohn's disease	0.000276	0.00344	CcSEcCtD
Sumatriptan—Abdominal discomfort—Mesalazine—Crohn's disease	0.000275	0.00343	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000274	0.00341	CcSEcCtD
Sumatriptan—Pancytopenia—Mesalazine—Crohn's disease	0.000273	0.0034	CcSEcCtD
Sumatriptan—Dysuria—Mesalazine—Crohn's disease	0.000269	0.00335	CcSEcCtD
Sumatriptan—Viral infection—Prednisone—Crohn's disease	0.000268	0.00334	CcSEcCtD
Sumatriptan—Pollakiuria—Mesalazine—Crohn's disease	0.000265	0.0033	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000262	0.00327	CcSEcCtD
Sumatriptan—Decreased appetite—Mercaptopurine—Crohn's disease	0.000262	0.00326	CcSEcCtD
Sumatriptan—Weight increased—Mesalazine—Crohn's disease	0.000261	0.00326	CcSEcCtD
Sumatriptan—Weight decreased—Mesalazine—Crohn's disease	0.00026	0.00324	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00026	0.00324	CcSEcCtD
Sumatriptan—Depression—Mesalazine—Crohn's disease	0.000255	0.00318	CcSEcCtD
Sumatriptan—Haemoglobin—Azathioprine—Crohn's disease	0.000254	0.00316	CcSEcCtD
Sumatriptan—ABCG2—lymph node—Crohn's disease	0.000253	0.00821	CbGeAlD
Sumatriptan—Haemorrhage—Azathioprine—Crohn's disease	0.000252	0.00314	CcSEcCtD
Sumatriptan—ABCB1—mammalian vulva—Crohn's disease	0.000249	0.00808	CbGeAlD
Sumatriptan—Conjunctivitis—Mesalazine—Crohn's disease	0.000249	0.0031	CcSEcCtD
Sumatriptan—Vasculitis—Prednisone—Crohn's disease	0.000248	0.00309	CcSEcCtD
Sumatriptan—Sweating—Mesalazine—Crohn's disease	0.000246	0.00306	CcSEcCtD
Sumatriptan—Haematuria—Mesalazine—Crohn's disease	0.000244	0.00304	CcSEcCtD
Sumatriptan—Hiccups—Prednisone—Crohn's disease	0.000242	0.00302	CcSEcCtD
Sumatriptan—Epistaxis—Mesalazine—Crohn's disease	0.000242	0.00301	CcSEcCtD
Sumatriptan—Sinusitis—Mesalazine—Crohn's disease	0.00024	0.00299	CcSEcCtD
Sumatriptan—Body temperature increased—Mercaptopurine—Crohn's disease	0.000238	0.00296	CcSEcCtD
Sumatriptan—Skin exfoliation—Prednisone—Crohn's disease	0.000231	0.00288	CcSEcCtD
Sumatriptan—Haemoglobin—Mesalazine—Crohn's disease	0.000231	0.00288	CcSEcCtD
Sumatriptan—Fluid retention—Prednisone—Crohn's disease	0.00023	0.00286	CcSEcCtD
Sumatriptan—Haemorrhage—Mesalazine—Crohn's disease	0.00023	0.00286	CcSEcCtD
Sumatriptan—Immune system disorder—Azathioprine—Crohn's disease	0.000228	0.00284	CcSEcCtD
Sumatriptan—Mediastinal disorder—Azathioprine—Crohn's disease	0.000228	0.00283	CcSEcCtD
Sumatriptan—Chills—Azathioprine—Crohn's disease	0.000227	0.00282	CcSEcCtD
Sumatriptan—Connective tissue disorder—Mesalazine—Crohn's disease	0.000226	0.00281	CcSEcCtD
Sumatriptan—Arrhythmia—Azathioprine—Crohn's disease	0.000226	0.00281	CcSEcCtD
Sumatriptan—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000222	0.00276	CcSEcCtD
Sumatriptan—ABCB1—lymphoid tissue—Crohn's disease	0.000221	0.00717	CbGeAlD
Sumatriptan—ABCB1—digestive system—Crohn's disease	0.000219	0.00709	CbGeAlD
Sumatriptan—Eye disorder—Mesalazine—Crohn's disease	0.000215	0.00268	CcSEcCtD
Sumatriptan—Tinnitus—Mesalazine—Crohn's disease	0.000214	0.00267	CcSEcCtD
Sumatriptan—Angiopathy—Mesalazine—Crohn's disease	0.000209	0.0026	CcSEcCtD
Sumatriptan—Euphoric mood—Prednisone—Crohn's disease	0.000208	0.00259	CcSEcCtD
Sumatriptan—Immune system disorder—Mesalazine—Crohn's disease	0.000208	0.00259	CcSEcCtD
Sumatriptan—Mediastinal disorder—Mesalazine—Crohn's disease	0.000207	0.00258	CcSEcCtD
Sumatriptan—Chills—Mesalazine—Crohn's disease	0.000206	0.00257	CcSEcCtD
Sumatriptan—Diarrhoea—Mercaptopurine—Crohn's disease	0.000206	0.00256	CcSEcCtD
Sumatriptan—Ill-defined disorder—Azathioprine—Crohn's disease	0.000204	0.00254	CcSEcCtD
Sumatriptan—Thrombophlebitis—Prednisone—Crohn's disease	0.000203	0.00253	CcSEcCtD
Sumatriptan—Anaemia—Azathioprine—Crohn's disease	0.000203	0.00253	CcSEcCtD
Sumatriptan—Erythema—Mesalazine—Crohn's disease	0.0002	0.00249	CcSEcCtD
Sumatriptan—Malaise—Azathioprine—Crohn's disease	0.000198	0.00247	CcSEcCtD
Sumatriptan—Flatulence—Mesalazine—Crohn's disease	0.000197	0.00246	CcSEcCtD
Sumatriptan—Dysgeusia—Mesalazine—Crohn's disease	0.000196	0.00244	CcSEcCtD
Sumatriptan—Back pain—Mesalazine—Crohn's disease	0.000194	0.00241	CcSEcCtD
Sumatriptan—Muscle spasms—Mesalazine—Crohn's disease	0.000192	0.0024	CcSEcCtD
Sumatriptan—Vomiting—Mercaptopurine—Crohn's disease	0.000191	0.00238	CcSEcCtD
Sumatriptan—Rash—Mercaptopurine—Crohn's disease	0.00019	0.00236	CcSEcCtD
Sumatriptan—Dermatitis—Mercaptopurine—Crohn's disease	0.00019	0.00236	CcSEcCtD
Sumatriptan—Tremor—Mesalazine—Crohn's disease	0.000188	0.00234	CcSEcCtD
Sumatriptan—Myalgia—Azathioprine—Crohn's disease	0.000187	0.00233	CcSEcCtD
Sumatriptan—Arthralgia—Azathioprine—Crohn's disease	0.000187	0.00233	CcSEcCtD
Sumatriptan—Ill-defined disorder—Mesalazine—Crohn's disease	0.000186	0.00231	CcSEcCtD
Sumatriptan—Anaemia—Mesalazine—Crohn's disease	0.000185	0.0023	CcSEcCtD
Sumatriptan—Discomfort—Azathioprine—Crohn's disease	0.000185	0.0023	CcSEcCtD
Sumatriptan—Angioedema—Mesalazine—Crohn's disease	0.000183	0.00228	CcSEcCtD
Sumatriptan—Malaise—Mesalazine—Crohn's disease	0.000181	0.00225	CcSEcCtD
Sumatriptan—Vertigo—Mesalazine—Crohn's disease	0.00018	0.00224	CcSEcCtD
Sumatriptan—Syncope—Mesalazine—Crohn's disease	0.00018	0.00224	CcSEcCtD
Sumatriptan—Nausea—Mercaptopurine—Crohn's disease	0.000179	0.00223	CcSEcCtD
Sumatriptan—Infection—Azathioprine—Crohn's disease	0.000178	0.00222	CcSEcCtD
Sumatriptan—Palpitations—Mesalazine—Crohn's disease	0.000177	0.0022	CcSEcCtD
Sumatriptan—Loss of consciousness—Mesalazine—Crohn's disease	0.000176	0.00219	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000176	0.00219	CcSEcCtD
Sumatriptan—Osteoarthritis—Prednisone—Crohn's disease	0.000176	0.00219	CcSEcCtD
Sumatriptan—Thrombocytopenia—Azathioprine—Crohn's disease	0.000176	0.00219	CcSEcCtD
Sumatriptan—Cough—Mesalazine—Crohn's disease	0.000175	0.00218	CcSEcCtD
Sumatriptan—Skin disorder—Azathioprine—Crohn's disease	0.000174	0.00217	CcSEcCtD
Sumatriptan—Hypertension—Mesalazine—Crohn's disease	0.000173	0.00215	CcSEcCtD
Sumatriptan—Myalgia—Mesalazine—Crohn's disease	0.00017	0.00212	CcSEcCtD
Sumatriptan—Arthralgia—Mesalazine—Crohn's disease	0.00017	0.00212	CcSEcCtD
Sumatriptan—Chest pain—Mesalazine—Crohn's disease	0.00017	0.00212	CcSEcCtD
Sumatriptan—Anxiety—Mesalazine—Crohn's disease	0.00017	0.00211	CcSEcCtD
Sumatriptan—Discomfort—Mesalazine—Crohn's disease	0.000168	0.0021	CcSEcCtD
Sumatriptan—Hypotension—Azathioprine—Crohn's disease	0.000168	0.00209	CcSEcCtD
Sumatriptan—Dry mouth—Mesalazine—Crohn's disease	0.000167	0.00208	CcSEcCtD
Sumatriptan—Confusional state—Mesalazine—Crohn's disease	0.000165	0.00205	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000163	0.00203	CcSEcCtD
Sumatriptan—Oedema—Mesalazine—Crohn's disease	0.000163	0.00203	CcSEcCtD
Sumatriptan—Anaphylactic shock—Mesalazine—Crohn's disease	0.000163	0.00203	CcSEcCtD
Sumatriptan—Infection—Mesalazine—Crohn's disease	0.000162	0.00202	CcSEcCtD
Sumatriptan—Shock—Mesalazine—Crohn's disease	0.000161	0.002	CcSEcCtD
Sumatriptan—Nervous system disorder—Mesalazine—Crohn's disease	0.00016	0.00199	CcSEcCtD
Sumatriptan—Thrombocytopenia—Mesalazine—Crohn's disease	0.00016	0.00199	CcSEcCtD
Sumatriptan—Tachycardia—Mesalazine—Crohn's disease	0.000159	0.00199	CcSEcCtD
Sumatriptan—Skin disorder—Mesalazine—Crohn's disease	0.000159	0.00198	CcSEcCtD
Sumatriptan—Hyperhidrosis—Mesalazine—Crohn's disease	0.000158	0.00197	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000155	0.00193	CcSEcCtD
Sumatriptan—Abdominal distension—Prednisone—Crohn's disease	0.000153	0.00191	CcSEcCtD
Sumatriptan—Hypotension—Mesalazine—Crohn's disease	0.000153	0.0019	CcSEcCtD
Sumatriptan—Pancreatitis—Prednisone—Crohn's disease	0.000149	0.00186	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000149	0.00185	CcSEcCtD
Sumatriptan—Feeling abnormal—Azathioprine—Crohn's disease	0.000148	0.00184	CcSEcCtD
Sumatriptan—Paraesthesia—Mesalazine—Crohn's disease	0.000147	0.00183	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000147	0.00183	CcSEcCtD
Sumatriptan—Dyspnoea—Mesalazine—Crohn's disease	0.000146	0.00181	CcSEcCtD
Sumatriptan—Somnolence—Mesalazine—Crohn's disease	0.000145	0.00181	CcSEcCtD
Sumatriptan—Decreased appetite—Mesalazine—Crohn's disease	0.000142	0.00177	CcSEcCtD
Sumatriptan—Abdominal pain—Azathioprine—Crohn's disease	0.000142	0.00177	CcSEcCtD
Sumatriptan—Body temperature increased—Azathioprine—Crohn's disease	0.000142	0.00177	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000141	0.00176	CcSEcCtD
Sumatriptan—Fatigue—Mesalazine—Crohn's disease	0.000141	0.00175	CcSEcCtD
Sumatriptan—Constipation—Mesalazine—Crohn's disease	0.00014	0.00174	CcSEcCtD
Sumatriptan—Pain—Mesalazine—Crohn's disease	0.00014	0.00174	CcSEcCtD
Sumatriptan—Weight increased—Prednisone—Crohn's disease	0.000138	0.00172	CcSEcCtD
Sumatriptan—Weight decreased—Prednisone—Crohn's disease	0.000138	0.00171	CcSEcCtD
Sumatriptan—Hyperglycaemia—Prednisone—Crohn's disease	0.000137	0.00171	CcSEcCtD
Sumatriptan—Depression—Prednisone—Crohn's disease	0.000135	0.00168	CcSEcCtD
Sumatriptan—Feeling abnormal—Mesalazine—Crohn's disease	0.000135	0.00168	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Prednisone—Crohn's disease	0.000134	0.00166	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000134	0.00166	CcSEcCtD
Sumatriptan—Myocardial infarction—Prednisone—Crohn's disease	0.000133	0.00165	CcSEcCtD
Sumatriptan—Hypersensitivity—Azathioprine—Crohn's disease	0.000132	0.00165	CcSEcCtD
Sumatriptan—Urticaria—Mesalazine—Crohn's disease	0.00013	0.00162	CcSEcCtD
Sumatriptan—Body temperature increased—Mesalazine—Crohn's disease	0.000129	0.00161	CcSEcCtD
Sumatriptan—Abdominal pain—Mesalazine—Crohn's disease	0.000129	0.00161	CcSEcCtD
Sumatriptan—ABCB1—lymph node—Crohn's disease	0.000125	0.00405	CbGeAlD
Sumatriptan—Bradycardia—Prednisone—Crohn's disease	0.000124	0.00154	CcSEcCtD
Sumatriptan—Diarrhoea—Azathioprine—Crohn's disease	0.000123	0.00153	CcSEcCtD
Sumatriptan—Haemoglobin—Prednisone—Crohn's disease	0.000122	0.00152	CcSEcCtD
Sumatriptan—Haemorrhage—Prednisone—Crohn's disease	0.000122	0.00151	CcSEcCtD
Sumatriptan—Hallucination—Prednisone—Crohn's disease	0.000121	0.00151	CcSEcCtD
Sumatriptan—Hypersensitivity—Mesalazine—Crohn's disease	0.00012	0.0015	CcSEcCtD
Sumatriptan—Connective tissue disorder—Prednisone—Crohn's disease	0.00012	0.00149	CcSEcCtD
Sumatriptan—Dizziness—Azathioprine—Crohn's disease	0.000119	0.00148	CcSEcCtD
Sumatriptan—Asthenia—Mesalazine—Crohn's disease	0.000117	0.00146	CcSEcCtD
Sumatriptan—Pruritus—Mesalazine—Crohn's disease	0.000116	0.00144	CcSEcCtD
Sumatriptan—Vomiting—Azathioprine—Crohn's disease	0.000114	0.00142	CcSEcCtD
Sumatriptan—Eye disorder—Prednisone—Crohn's disease	0.000114	0.00142	CcSEcCtD
Sumatriptan—Rash—Azathioprine—Crohn's disease	0.000113	0.00141	CcSEcCtD
Sumatriptan—Dermatitis—Azathioprine—Crohn's disease	0.000113	0.00141	CcSEcCtD
Sumatriptan—Flushing—Prednisone—Crohn's disease	0.000113	0.00141	CcSEcCtD
Sumatriptan—Headache—Azathioprine—Crohn's disease	0.000112	0.0014	CcSEcCtD
Sumatriptan—Diarrhoea—Mesalazine—Crohn's disease	0.000112	0.00139	CcSEcCtD
Sumatriptan—Angiopathy—Prednisone—Crohn's disease	0.00011	0.00137	CcSEcCtD
Sumatriptan—Immune system disorder—Prednisone—Crohn's disease	0.00011	0.00137	CcSEcCtD
Sumatriptan—Arrhythmia—Prednisone—Crohn's disease	0.000109	0.00135	CcSEcCtD
Sumatriptan—Dizziness—Mesalazine—Crohn's disease	0.000108	0.00135	CcSEcCtD
Sumatriptan—Nausea—Azathioprine—Crohn's disease	0.000107	0.00133	CcSEcCtD
Sumatriptan—Erythema—Prednisone—Crohn's disease	0.000106	0.00132	CcSEcCtD
Sumatriptan—Vomiting—Mesalazine—Crohn's disease	0.000104	0.00129	CcSEcCtD
Sumatriptan—Rash—Mesalazine—Crohn's disease	0.000103	0.00128	CcSEcCtD
Sumatriptan—Dermatitis—Mesalazine—Crohn's disease	0.000103	0.00128	CcSEcCtD
Sumatriptan—Headache—Mesalazine—Crohn's disease	0.000102	0.00127	CcSEcCtD
Sumatriptan—Ill-defined disorder—Prednisone—Crohn's disease	9.83e-05	0.00122	CcSEcCtD
Sumatriptan—Anaemia—Prednisone—Crohn's disease	9.79e-05	0.00122	CcSEcCtD
Sumatriptan—Agitation—Prednisone—Crohn's disease	9.73e-05	0.00121	CcSEcCtD
Sumatriptan—Nausea—Mesalazine—Crohn's disease	9.7e-05	0.00121	CcSEcCtD
Sumatriptan—Angioedema—Prednisone—Crohn's disease	9.68e-05	0.00121	CcSEcCtD
Sumatriptan—Malaise—Prednisone—Crohn's disease	9.55e-05	0.00119	CcSEcCtD
Sumatriptan—Vertigo—Prednisone—Crohn's disease	9.52e-05	0.00118	CcSEcCtD
Sumatriptan—Syncope—Prednisone—Crohn's disease	9.5e-05	0.00118	CcSEcCtD
Sumatriptan—Loss of consciousness—Prednisone—Crohn's disease	9.31e-05	0.00116	CcSEcCtD
Sumatriptan—Convulsion—Prednisone—Crohn's disease	9.18e-05	0.00114	CcSEcCtD
Sumatriptan—Hypertension—Prednisone—Crohn's disease	9.14e-05	0.00114	CcSEcCtD
Sumatriptan—Myalgia—Prednisone—Crohn's disease	9.02e-05	0.00112	CcSEcCtD
Sumatriptan—Arthralgia—Prednisone—Crohn's disease	9.02e-05	0.00112	CcSEcCtD
Sumatriptan—Anxiety—Prednisone—Crohn's disease	8.99e-05	0.00112	CcSEcCtD
Sumatriptan—Discomfort—Prednisone—Crohn's disease	8.91e-05	0.00111	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisone—Crohn's disease	8.64e-05	0.00108	CcSEcCtD
Sumatriptan—Oedema—Prednisone—Crohn's disease	8.64e-05	0.00108	CcSEcCtD
Sumatriptan—Infection—Prednisone—Crohn's disease	8.59e-05	0.00107	CcSEcCtD
Sumatriptan—Shock—Prednisone—Crohn's disease	8.5e-05	0.00106	CcSEcCtD
Sumatriptan—Nervous system disorder—Prednisone—Crohn's disease	8.48e-05	0.00106	CcSEcCtD
Sumatriptan—Tachycardia—Prednisone—Crohn's disease	8.44e-05	0.00105	CcSEcCtD
Sumatriptan—Skin disorder—Prednisone—Crohn's disease	8.4e-05	0.00105	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisone—Crohn's disease	8.36e-05	0.00104	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Prednisone—Crohn's disease	7.88e-05	0.000981	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisone—Crohn's disease	7.76e-05	0.000966	CcSEcCtD
Sumatriptan—Decreased appetite—Prednisone—Crohn's disease	7.51e-05	0.000936	CcSEcCtD
Sumatriptan—Fatigue—Prednisone—Crohn's disease	7.45e-05	0.000928	CcSEcCtD
Sumatriptan—Constipation—Prednisone—Crohn's disease	7.39e-05	0.00092	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisone—Crohn's disease	7.12e-05	0.000887	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Prednisone—Crohn's disease	7.07e-05	0.00088	CcSEcCtD
Sumatriptan—Urticaria—Prednisone—Crohn's disease	6.87e-05	0.000855	CcSEcCtD
Sumatriptan—Body temperature increased—Prednisone—Crohn's disease	6.83e-05	0.000851	CcSEcCtD
Sumatriptan—Abdominal pain—Prednisone—Crohn's disease	6.83e-05	0.000851	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisone—Crohn's disease	6.37e-05	0.000793	CcSEcCtD
Sumatriptan—Asthenia—Prednisone—Crohn's disease	6.2e-05	0.000772	CcSEcCtD
Sumatriptan—Pruritus—Prednisone—Crohn's disease	6.12e-05	0.000761	CcSEcCtD
Sumatriptan—Diarrhoea—Prednisone—Crohn's disease	5.91e-05	0.000736	CcSEcCtD
Sumatriptan—Dizziness—Prednisone—Crohn's disease	5.72e-05	0.000712	CcSEcCtD
Sumatriptan—Vomiting—Prednisone—Crohn's disease	5.5e-05	0.000684	CcSEcCtD
Sumatriptan—Rash—Prednisone—Crohn's disease	5.45e-05	0.000679	CcSEcCtD
Sumatriptan—Dermatitis—Prednisone—Crohn's disease	5.44e-05	0.000678	CcSEcCtD
Sumatriptan—Headache—Prednisone—Crohn's disease	5.42e-05	0.000674	CcSEcCtD
Sumatriptan—Nausea—Prednisone—Crohn's disease	5.13e-05	0.000639	CcSEcCtD
Sumatriptan—HTR1F—Signaling by GPCR—RASGRP1—Crohn's disease	3.09e-05	0.00129	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MTMR3—Crohn's disease	3.09e-05	0.00129	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCR9—Crohn's disease	3.07e-05	0.00128	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—PTGER4—Crohn's disease	3.06e-05	0.00128	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CCR6—Crohn's disease	3e-05	0.00125	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCR9—Crohn's disease	2.97e-05	0.00124	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—IFNG—Crohn's disease	2.95e-05	0.00123	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CCR6—Crohn's disease	2.94e-05	0.00122	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	2.93e-05	0.00122	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.91e-05	0.00121	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PLA2G4F—Crohn's disease	2.88e-05	0.0012	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—MTMR3—Crohn's disease	2.86e-05	0.00119	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—GPR65—Crohn's disease	2.85e-05	0.00119	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—CXCL8—Crohn's disease	2.83e-05	0.00118	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.82e-05	0.00118	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.82e-05	0.00118	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.81e-05	0.00117	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RSPO3—Crohn's disease	2.8e-05	0.00117	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—CXCL8—Crohn's disease	2.77e-05	0.00115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ACKR2—Crohn's disease	2.76e-05	0.00115	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—GPR65—Crohn's disease	2.76e-05	0.00115	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RSPO3—Crohn's disease	2.74e-05	0.00114	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	2.74e-05	0.00114	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CCR6—Crohn's disease	2.73e-05	0.00114	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCR9—Crohn's disease	2.69e-05	0.00112	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—ALB—Crohn's disease	2.68e-05	0.00112	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—CXCL8—Crohn's disease	2.68e-05	0.00111	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCR6—Crohn's disease	2.67e-05	0.00111	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SEL1L—Crohn's disease	2.66e-05	0.00111	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PTGER4—Crohn's disease	2.64e-05	0.0011	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MTMR3—Crohn's disease	2.64e-05	0.0011	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—IL1B—Crohn's disease	2.63e-05	0.00109	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MLN—Crohn's disease	2.62e-05	0.00109	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SEL1L—Crohn's disease	2.6e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PTGER4—Crohn's disease	2.59e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCR6—Crohn's disease	2.52e-05	0.00105	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GPR65—Crohn's disease	2.5e-05	0.00104	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.49e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—IL2RA—Crohn's disease	2.47e-05	0.00103	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTMR3—Crohn's disease	2.45e-05	0.00102	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCR9—Crohn's disease	2.43e-05	0.00101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ACKR2—Crohn's disease	2.42e-05	0.00101	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—FADS1—Crohn's disease	2.41e-05	0.001	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PTGER4—Crohn's disease	2.4e-05	0.000999	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.4e-05	0.000998	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TAGAP—Crohn's disease	2.39e-05	0.000996	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCR9—Crohn's disease	2.38e-05	0.000991	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PTGER4—Crohn's disease	2.35e-05	0.000978	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MLN—Crohn's disease	2.3e-05	0.000956	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RBX1—Crohn's disease	2.28e-05	0.000948	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GPR65—Crohn's disease	2.26e-05	0.000941	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GPX4—Crohn's disease	2.25e-05	0.000938	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL3—Crohn's disease	2.25e-05	0.000937	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.25e-05	0.000936	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL2RA—Crohn's disease	2.24e-05	0.000932	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CCR6—Crohn's disease	2.24e-05	0.000932	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—FADS1—Crohn's disease	2.23e-05	0.000928	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTGER4—Crohn's disease	2.22e-05	0.000923	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GPR65—Crohn's disease	2.21e-05	0.000921	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL3—Crohn's disease	2.2e-05	0.000918	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.2e-05	0.000916	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—RASGRP1—Crohn's disease	2.18e-05	0.000907	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GCKR—Crohn's disease	2.18e-05	0.000906	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—RASGRP1—Crohn's disease	2.13e-05	0.000888	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—CXCL8—Crohn's disease	2.11e-05	0.000878	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TAGAP—Crohn's disease	2.1e-05	0.000875	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RSPO3—Crohn's disease	2.09e-05	0.000871	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GPX4—Crohn's disease	2.09e-05	0.000869	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—FADS1—Crohn's disease	2.06e-05	0.000857	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL3—Crohn's disease	2.04e-05	0.000851	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.04e-05	0.000848	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCR6—Crohn's disease	2.03e-05	0.000847	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GCKR—Crohn's disease	2.02e-05	0.00084	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL3—Crohn's disease	2e-05	0.000833	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—UBE2D1—Crohn's disease	2e-05	0.000831	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.99e-05	0.000828	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SEL1L—Crohn's disease	1.98e-05	0.000825	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—RASGRP1—Crohn's disease	1.98e-05	0.000823	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PTGER4—Crohn's disease	1.97e-05	0.000821	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	1.97e-05	0.000819	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RIPK2—Crohn's disease	1.94e-05	0.000806	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—RASGRP1—Crohn's disease	1.94e-05	0.000806	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.93e-05	0.000805	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GPX4—Crohn's disease	1.93e-05	0.000802	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—TNF—Crohn's disease	1.91e-05	0.000795	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—FADS1—Crohn's disease	1.9e-05	0.000793	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL3—Crohn's disease	1.89e-05	0.000786	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GCKR—Crohn's disease	1.86e-05	0.000775	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	1.85e-05	0.000771	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RSPO3—Crohn's disease	1.84e-05	0.000765	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RASGRP1—Crohn's disease	1.83e-05	0.00076	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR9—Crohn's disease	1.81e-05	0.000755	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PTGER4—Crohn's disease	1.79e-05	0.000745	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCR6—Crohn's disease	1.78e-05	0.000743	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GPX4—Crohn's disease	1.78e-05	0.000743	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.76e-05	0.000732	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SEL1L—Crohn's disease	1.74e-05	0.000725	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	1.73e-05	0.000721	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GCKR—Crohn's disease	1.72e-05	0.000717	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—CXCL8—Crohn's disease	1.71e-05	0.000713	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GPR65—Crohn's disease	1.69e-05	0.000702	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL3—Crohn's disease	1.68e-05	0.000699	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.68e-05	0.000698	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—CXCL8—Crohn's disease	1.68e-05	0.000698	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—JAK2—Crohn's disease	1.66e-05	0.00069	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SOCS1—Crohn's disease	1.65e-05	0.000689	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.64e-05	0.000685	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—RASGRP1—Crohn's disease	1.62e-05	0.000676	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCR6—Crohn's disease	1.61e-05	0.00067	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR9—Crohn's disease	1.59e-05	0.000663	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—TYK2—Crohn's disease	1.58e-05	0.000657	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2RA—Crohn's disease	1.58e-05	0.000657	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCR6—Crohn's disease	1.58e-05	0.000657	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	1.57e-05	0.000654	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.55e-05	0.000648	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PLA2G4F—Crohn's disease	1.55e-05	0.000648	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2RA—Crohn's disease	1.54e-05	0.000643	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL3—Crohn's disease	1.52e-05	0.000635	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—CXCL8—Crohn's disease	1.51e-05	0.00063	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—JAK2—Crohn's disease	1.5e-05	0.000627	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GPR65—Crohn's disease	1.48e-05	0.000616	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.48e-05	0.000616	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	1.47e-05	0.000614	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL3—Crohn's disease	1.47e-05	0.000614	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.47e-05	0.000613	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RBX1—Crohn's disease	1.46e-05	0.000606	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2RA—Crohn's disease	1.43e-05	0.000596	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SMAD3—Crohn's disease	1.43e-05	0.000595	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RBX1—Crohn's disease	1.43e-05	0.000594	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	1.43e-05	0.000594	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTGER4—Crohn's disease	1.42e-05	0.00059	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2RA—Crohn's disease	1.4e-05	0.000584	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.39e-05	0.000581	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTGER4—Crohn's disease	1.39e-05	0.000578	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CXCL8—Crohn's disease	1.37e-05	0.000572	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.36e-05	0.000567	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL3—Crohn's disease	1.34e-05	0.000557	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.33e-05	0.000554	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2RA—Crohn's disease	1.32e-05	0.000551	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTMR3—Crohn's disease	1.32e-05	0.000551	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	1.29e-05	0.000539	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—UBE2D1—Crohn's disease	1.28e-05	0.000532	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	1.28e-05	0.000532	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.26e-05	0.000527	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—UBE2D1—Crohn's disease	1.25e-05	0.000521	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RIPK2—Crohn's disease	1.24e-05	0.000516	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RIPK2—Crohn's disease	1.21e-05	0.000505	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL3—Crohn's disease	1.21e-05	0.000503	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR6—Crohn's disease	1.2e-05	0.0005	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL3—Crohn's disease	1.18e-05	0.000492	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—IL6—Crohn's disease	1.18e-05	0.000491	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	1.18e-05	0.00049	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.17e-05	0.000488	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RASGRP1—Crohn's disease	1.17e-05	0.000486	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.16e-05	0.000484	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RASGRP1—Crohn's disease	1.14e-05	0.000476	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	1.12e-05	0.000467	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RBX1—Crohn's disease	1.09e-05	0.000452	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	1.07e-05	0.000445	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—JAK2—Crohn's disease	1.06e-05	0.000441	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SOCS1—Crohn's disease	1.06e-05	0.000441	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	1.06e-05	0.00044	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR6—Crohn's disease	1.05e-05	0.000439	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—JAK2—Crohn's disease	1.04e-05	0.000432	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SOCS1—Crohn's disease	1.04e-05	0.000431	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	1.03e-05	0.00043	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—FADS1—Crohn's disease	1.03e-05	0.000429	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TYK2—Crohn's disease	1.01e-05	0.00042	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TYK2—Crohn's disease	9.88e-06	0.000411	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CXCL8—Crohn's disease	9.67e-06	0.000403	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX4—Crohn's disease	9.64e-06	0.000402	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—JAK2—Crohn's disease	9.62e-06	0.000401	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RBX1—Crohn's disease	9.53e-06	0.000397	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	9.52e-06	0.000397	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CXCL8—Crohn's disease	9.47e-06	0.000394	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	9.42e-06	0.000392	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.41e-06	0.000392	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	9.38e-06	0.00039	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TYK2—Crohn's disease	9.32e-06	0.000388	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCKR—Crohn's disease	9.31e-06	0.000388	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTGER4—Crohn's disease	9.28e-06	0.000387	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	9.23e-06	0.000385	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SMAD3—Crohn's disease	9.13e-06	0.00038	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL3—Crohn's disease	9e-06	0.000375	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	8.94e-06	0.000372	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—JAK2—Crohn's disease	8.89e-06	0.00037	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	8.78e-06	0.000366	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	8.71e-06	0.000363	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	8.6e-06	0.000358	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	8.46e-06	0.000352	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	8.36e-06	0.000348	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	8.28e-06	0.000345	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL8—Crohn's disease	8.11e-06	0.000338	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RIPK2—Crohn's disease	8.11e-06	0.000338	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL3—Crohn's disease	7.91e-06	0.000329	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	7.9e-06	0.000329	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	7.89e-06	0.000329	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—Crohn's disease	7.71e-06	0.000321	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	7.65e-06	0.000318	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	7.52e-06	0.000313	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	7.21e-06	0.0003	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	7.18e-06	0.000299	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	6.94e-06	0.000289	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SOCS1—Crohn's disease	6.93e-06	0.000289	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—Crohn's disease	6.92e-06	0.000288	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	6.81e-06	0.000284	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TYK2—Crohn's disease	6.61e-06	0.000275	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	6.55e-06	0.000273	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—STAT3—Crohn's disease	6.52e-06	0.000272	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—Crohn's disease	6.42e-06	0.000267	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	6.33e-06	0.000264	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.33e-06	0.000264	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	6.31e-06	0.000263	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—JAK2—Crohn's disease	6.3e-06	0.000262	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—Crohn's disease	6.06e-06	0.000252	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SMAD3—Crohn's disease	5.98e-06	0.000249	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TYK2—Crohn's disease	5.96e-06	0.000248	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—Crohn's disease	5.92e-06	0.000247	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TYK2—Crohn's disease	5.83e-06	0.000243	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	5.75e-06	0.00024	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JAK2—Crohn's disease	5.68e-06	0.000237	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—Crohn's disease	5.61e-06	0.000234	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JAK2—Crohn's disease	5.57e-06	0.000232	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2RA—Crohn's disease	5.54e-06	0.000231	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—Crohn's disease	5.48e-06	0.000228	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	5.19e-06	0.000216	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—Crohn's disease	5.18e-06	0.000216	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	5.08e-06	0.000212	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—Crohn's disease	4.93e-06	0.000205	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—Crohn's disease	4.83e-06	0.000201	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—Crohn's disease	4.8e-06	0.0002	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—Crohn's disease	4.56e-06	0.00019	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TYK2—Crohn's disease	4.44e-06	0.000185	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JAK2—Crohn's disease	4.24e-06	0.000177	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—Crohn's disease	4.17e-06	0.000174	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—Crohn's disease	4.09e-06	0.00017	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TYK2—Crohn's disease	3.9e-06	0.000163	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.87e-06	0.000161	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JAK2—Crohn's disease	3.72e-06	0.000155	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—Crohn's disease	3.68e-06	0.000153	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—Crohn's disease	3.4e-06	0.000141	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—Crohn's disease	3.23e-06	0.000135	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—Crohn's disease	3.11e-06	0.00013	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—Crohn's disease	2.96e-06	0.000123	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—Crohn's disease	2.91e-06	0.000121	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—Crohn's disease	2.85e-06	0.000119	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—Crohn's disease	2.73e-06	0.000114	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—Crohn's disease	2.59e-06	0.000108	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—Crohn's disease	2.17e-06	9.05e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—Crohn's disease	1.91e-06	7.95e-05	CbGpPWpGaD
